Biologics
Biologics is one of the most exciting areas of therapeutic medicine and may represent about one in every four newly commercialized drugs in the future. This revolution in biology-based drug discovery and development is a natural complement to the small molecule, chemistry-based heritage here at Bristol-Myers Squibb. In fact, our evolving focus on biologics and our traditional pharmaceutical expertise serve as the key strategic platform for our transformation to a next-generation BioPharma company.
Biologics is not new to drug discovery nor is it new to Bristol-Myers Squibb. For the past 20 years, our scientists have increasingly made use of a wide range of innovative technologies to discover and analyze new biologic therapies. These molecular biology-based approaches, including bioinformatics, protein engineering, genomics and biomedical imaging, allow us to address the numerous disease targets that cannot be easily modulated by more traditional pharmaceuticals.
We will continue to build our biologics capabilities through strategic technology acquisitions, targeted licensing opportunities and through our own rigorous discovery and development programs. In addition, we are currently constructing a dedicated biologics production facility in Devens, Massachusetts.
We are seeking highly motivated people with a real passion for drug discovery and development to join the Bristol-Myers Squibb R&D team. We are specifically looking for candidates who possess a background(s) in biochemistry, molecular biology and protein biochemistry, or biology, with a proven ability to apply technical skills in a multidisciplinary science setting.